JP2007518719A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518719A5
JP2007518719A5 JP2006547254A JP2006547254A JP2007518719A5 JP 2007518719 A5 JP2007518719 A5 JP 2007518719A5 JP 2006547254 A JP2006547254 A JP 2006547254A JP 2006547254 A JP2006547254 A JP 2006547254A JP 2007518719 A5 JP2007518719 A5 JP 2007518719A5
Authority
JP
Japan
Prior art keywords
group
para
substituted
compound
chalcone oxime
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006547254A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007518719A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/042892 external-priority patent/WO2005066115A2/en
Publication of JP2007518719A publication Critical patent/JP2007518719A/ja
Publication of JP2007518719A5 publication Critical patent/JP2007518719A5/ja
Pending legal-status Critical Current

Links

JP2006547254A 2003-12-26 2004-12-21 RARγレチノイド受容体アンタゴニスト活性を有する二置換カルコンオキシム Pending JP2007518719A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53283503P 2003-12-26 2003-12-26
PCT/US2004/042892 WO2005066115A2 (en) 2003-12-26 2004-12-21 Disubstituted chalcone oximes having rarϝ retinoid receptor antagonist activity

Publications (2)

Publication Number Publication Date
JP2007518719A JP2007518719A (ja) 2007-07-12
JP2007518719A5 true JP2007518719A5 (enExample) 2007-12-13

Family

ID=34748824

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006547254A Pending JP2007518719A (ja) 2003-12-26 2004-12-21 RARγレチノイド受容体アンタゴニスト活性を有する二置換カルコンオキシム

Country Status (8)

Country Link
US (2) US7253319B2 (enExample)
EP (1) EP1701934B1 (enExample)
JP (1) JP2007518719A (enExample)
AT (1) ATE423761T1 (enExample)
CA (1) CA2551294A1 (enExample)
DE (1) DE602004019685D1 (enExample)
MX (1) MXPA06007255A (enExample)
WO (1) WO2005066115A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7476673B2 (en) * 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
CN101481352A (zh) 2008-01-10 2009-07-15 上海恒瑞医药有限公司 双环取代吡唑酮偶氮类衍生物、其制备方法及其在医药上的应用
AU2010214607B2 (en) 2009-02-10 2012-05-31 Nippon Soda Co., Ltd. Nitrogen-containing compounds and harmful organism control agents
CN101921232A (zh) 2009-06-11 2010-12-22 上海恒瑞医药有限公司 双环取代吡唑酮偶氮类衍生物的盐,其制备方法及其在医药上的应用
KR20120093428A (ko) 2009-12-14 2012-08-22 메르크 파텐트 게엠베하 스핑고신 키나아제 저해제
US8907098B2 (en) 2009-12-17 2014-12-09 Merck Patent Gmbh Inhibitors of sphingosine kinase
US20140194517A1 (en) * 2013-01-08 2014-07-10 Io Therapeutics, Inc. Treatment of Graft-Versus-Host Disease Disorders using RAR Antagonists
CN110090237B (zh) * 2019-05-30 2021-05-28 四川农业大学 一种用于治疗维生素a中毒所致肝损伤和骨损伤的药物及用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140613A (fr) 1979-08-22 1983-02-01 Leo Jouk Velo a cadre telescopique adaptable en velo d'appartement
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
DE69224660C5 (de) 1991-12-18 2010-06-02 The Salk Institute For Biological Studies, La Jolla Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen
US5612356A (en) 1992-12-28 1997-03-18 Eisai Co., Ltd. Heterocycle-containing carbonic acid derivatives
US5455265A (en) * 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US5599967A (en) * 1994-12-29 1997-02-04 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
US5952345A (en) * 1995-09-01 1999-09-14 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5958954A (en) * 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5776699A (en) * 1995-09-01 1998-07-07 Allergan, Inc. Method of identifying negative hormone and/or antagonist activities
US5877207A (en) * 1996-03-11 1999-03-02 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5723666A (en) * 1996-06-21 1998-03-03 Allergan Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
PT101919B (pt) * 1996-09-30 2000-01-31 Hovione Sociedade Quimica Sa Um processo para a purificacao de tohexol
US5739338A (en) * 1996-11-05 1998-04-14 Allergan N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
US5760276A (en) * 1997-03-06 1998-06-02 Allergan Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
US6037488A (en) * 1997-04-19 2000-03-14 Allergan Sales, Inc. Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
US5919970A (en) * 1997-04-24 1999-07-06 Allergan Sales, Inc. Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
US20030114482A1 (en) * 1999-12-15 2003-06-19 Maurizio Pacifici Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
US6313168B1 (en) * 1999-12-15 2001-11-06 Allergan Sales, Inc. Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies
DK1324970T3 (da) * 2000-10-02 2009-01-05 Hoffmann La Roche Retinoider til behandling af emfysem
US20020193403A1 (en) * 2001-05-03 2002-12-19 Allergan Sales, Inc. Methods of treating hyperlipidemia

Similar Documents

Publication Publication Date Title
USD550141S1 (en) Wheel
USD554491S1 (en) Spring
JP2006524283A5 (enExample)
USD537470S1 (en) Type font
USD624614S1 (en) Dumbbell
JP2006503588A5 (enExample)
USD546379S1 (en) Type font
USD538843S1 (en) Type font
USD498274S1 (en) Ball
JP2005510235A5 (enExample)
USD580965S1 (en) Typeface
USD577311S1 (en) State magnet
USD562415S1 (en) Barbell weightlifting plate
JP2006520662A5 (enExample)
JP2006506499A5 (enExample)
USD568025S1 (en) Barrel
JP2009520682A5 (enExample)
USD537952S1 (en) Cart corral
JP2007510403A5 (enExample)
JP2005315264A5 (enExample)
JP2006512466A5 (enExample)
JP2007518719A5 (enExample)
USD571652S1 (en) Door stop
USD521102S1 (en) Fly trap
JP2006156938A5 (enExample)